CASE REPORT
Accepted on 03 Apr 2026
- Frontiers in Medicine
- Translational Medicine
- Research Topics
- Molecular Drivers of Cancer Therapy Resistance: Mechanisms and Translational Opportunities
Molecular Drivers of Cancer Therapy Resistance: Mechanisms and Translational Opportunities
263
Total downloads
4,239
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
PERSPECTIVE
Published on 25 Mar 2026
Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3–linked immune exclusion in melanoma: mechanisms and translational opportunities
doi 10.3389/fmed.2026.1807470
CASE REPORT
Published on 23 Mar 2026
ETV6-NTRK3 as a resistance mechanism to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: favorable response after combination of osimertinib and entrectinib: a case report and literature review
doi 10.3389/fphar.2026.1762137
CASE REPORT
Published on 16 Jan 2026
Cold agglutinin syndrome in a patient with metastatic breast cancer: a Case Report
doi 10.3389/fmed.2025.1711809
- 811 views
OPINION
Published on 15 Jan 2026
MUC13 is a crucial player in YAP1-β-catenin survival complex mediated cancer metastasis
doi 10.3389/fmed.2025.1727498
- 641 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.